EP
OM icon

Eversept Partners’s Outset Medical OM Stock Holding History

Eversept Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,167
Closed -$2.35M – 124
2021
Q3 		$2.35M Sell
3,167
-3,986
-56% -$2.72M 0.16% 71
2021
Q2 		$5.36M Buy
+7,153
New +$5.47M 0.36% 45

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eversept Partners's OM Position: Q4 2021 in Review

Eversept Partners sold out of Outset Medical (OM) in Q4 2021, closing a stake of 3,167 shares — an estimated $2.35M sold.

Eversept Partners first reported a position in OM in Q2 2021 and held it in 2 quarters. The position peaked at $5.36M in Q2 2021. 156 funds tracked by Wall St. Rank hold OM as of Q4 2021.

  • Eversept Partners reported no remaining Outset Medical position as of Q4 2021 after selling out during the quarter.
  • Eversept Partners sold 3,167 Outset Medical shares in Q4 2021, an estimated $2.35M.
  • Eversept Partners first reported a position in Outset Medical in Q2 2021 and held it in 2 quarters.
  • Eversept Partners's Outset Medical position peaked at $5.36M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Outset Medical as of Q4 2021.

Based on Eversept Partners's 13F filing for Q4 2021, filed 14 Feb 2022.